June 2020

Jun

Biofortuna appointed as CMO for QuantuMDx CE–marked assay

Biofortuna has provided assay development and manufacturing support to QuantuMDx Group Limited to assist in the manufacturing scale-up, regulatory approval and launch of their rapid, sensitive SARS-CoV-2 test.

Biofortuna

Biofortuna is a specialist contract development and manufacturing organisation providing Genomic services, custom development and manufacturing support.

Operating from state-of-the art, humidity-controlled premises, and benefiting from ISO 17025 accreditation, ISO 13485 certification and FDA registration, we have a proven track record in the development and large-scale manufacture of PCR and LAMP molecular assays and Immunoassays.